Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
Reduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma.
What do you tell the family who asks, 'What went wrong?' The truth and nothing but the truth.
Dyspnea and dysphagia from upper airway obstruction after occipitocervical fusion in the pediatric age group.
MET as a drug target.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET as a drug target.
MET as a drug target. Clin Adv Hematol Oncol. 2015 Jun; 13(6):351-3.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials as Topic
Humans
Neoplasms
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia